American Journal of Drug and Alcohol Abuse

Article	Citations
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population	54
Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies	46
Dopamine D2/D3 receptor availability and working memory in stimulant use disorder	38
Assessment of liability to substance use disorder induced by two emerging stimulants, 4,4′-dimethylaminorex and escaline, in mice	27
Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey	22
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder	22
Differential effects of moderate chronic ethanol consumption on neurobehavior, white matter glial protein expression, and mTOR pathway signaling with adolescent brain maturation	21
Alcohol-related non-fatal motor vehicle crash injury in the US from 2019 to 2022	18
Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances	18
Assessing factors associated with knowledge of Driving Under the Influence (DUI) penalties	18
Internet-based, continuously available Narcotics Anonymous meetings: a new resource for access to Twelve Step support for abstinence	16
In utero chronic cannabis exposure is associated with lower total brain volume in the first month of postnatal life	16
Opioid overdose after extended-release buprenorphine injection: a case report	16
Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies	16
Addressing stimulant use disorder through state opioid response grants from the substance abuse and mental health services administration: Missouri’s initial approach	16
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial	16
Association of drinking behaviors with TXNIP DNA methylation levels in leukocytes among the general Japanese population	16
Many leveled ordinal models for frequency of alcohol and drug use	16
Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes	15
Correction	15
A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results	15
Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products	15
Withdrawal interference scale: a novel measure of withdrawal-related life disruption in opioid use disorder and alcohol use disorder	14
Assessment of patient perception of treatment assignment and patient-reported outcomes in a cannabis use disorder trial	14
Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies	13

Social influence on drug use and sexual behaviors among rural LGBTQ+ individuals	13
Racial/ethnic group comparisons of quit ratios and prevalences of cessation-related factors among adults who smoke with a quit attempt	13
Development and initial findings from the Peer Recovery Coach (PRC) checklist: a new tool to assess the nature of peer recovery coaching service delivery	13
Changes in frequency of cannabis use among people with HIV during the COVID-19 pandemic: a multi-methods study to explore the underlying reasons for change	12
The cost-effectiveness of long-term post-treatment peer recovery support services in the United States	12
Geographic trends in overall and long-acting opioid prescriptions under Medicaid and Medicare Part D in the United States, 2013–2021	12
Alterations in surface-based brain morphometry in men with opioid use disorder	12
Cocaine self-administration behavior is associated with subcortical and cortical morphometry measures in individuals with cocaine use disorder	11
X-ray absorption spectroscopy combined with deep learning for auto and rapid illicit drug detection	11
Plasma leptin levels are lower in females, but not males, with ketamine use disorder	11
Alcohol protective behavioral strategies for young adults: a content analysis across drinking contexts and gender	11
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use	10
Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults	10
Changes in attitudes toward alcohol control policies in Lithuania: findings from two representative surveys in 2015 and 2020	10
Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder	10
Gene knockdown of HCN2 ion channels in the ventral tegmental area reduces ethanol consumption in alcohol preferring rats	10
How much illegally manufactured fentanyl could the U.S. be consuming?	10
Age patterns and predictors of cannabis initiation among biracial and monoracial U.S. youth	9
Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders	9
Coroner county systems are associated with a higher likelihood of unclassified drug overdoses compared to medical examiner county systems	9
Large-scale longitudinal analysis of the progression of alcohol use among members of a social media platform: an observational study	9
Strategies to address co-occurring behavioral health needs among justice-involved youth	9
Flexibly modeling age trends in the prevalence of co-occurring patterns of substance use and mental health disorders using time-varying effects and latent class analysis	9
Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia	9
Psychometric properties of the Spanish Simultaneous Alcohol and Cannabis Motives Measure (S-SMM) and its short form (S-SMM-SF) among young adults	9
Meta-analysis of primary care delivered buprenorphine treatment retention outcomes	8
Challenges of obtaining accurate adolescent self-report of cannabis use	8
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study	8
Effects of fisetin on ethanol-induced rewarding properties in mice	8
Six-month length of stay associated with better recovery outcomes among residents of sober living houses	8
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review	8
Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity	8
Cannabis retail store density and county-level mortality from injury in the state of Washington from 2009–2020	8
Alterations in self-reported sensory gating and interoception in individuals frequently using cannabis	7
A study of long-term supraphysiologic-dose anabolic-androgenic steroid use on cognitive function in middle-aged men	7
Assessment of the Short Grit Scale in patients with substance use disorder: Psychometric properties and patient characteristics	7
Alcohol use and drinking motives across five countries: a post-COVID-19 pandemic update	7
Childhood trauma, intraindividual reaction time variability, baseline respiratory sinus arrhythmia, and perceived relapse tendency among males with substance use disorders	7
Improving Spanish translations of tobacco dependence measures using cognitive interviewing	7
Benefits of Alcoholics Anonymous affiliation among meeting attendees in Romania: a mixed methods approach	6
Fiduciary assignment as a potential intervention for substance use disorder: a retrospective chart review	6
Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population	6
Telehealth for opioid use disorder: retention as a function of demographics and rurality	6
Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder	6
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids	6
Ethanol causes non-communicable disease through activation of NLRP3 inflammasome: a review on mechanism of action and potential interventions	6
A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse	6
Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County	6
The global distribution and epidemiology of alcohol and drug use among street-involved children and youth: a meta-analysis	6
Buprenorphine in safety-sensitive positions	5

Protective effects of naringenin against methamphetamine-induced cell death in dopaminergic SH-SY5Y cells	5
The paradoxical association between tension-reduction alcohol outcome expectancies and tension following alcohol consumption	5
Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization	5
Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015–2023	5
Synergistic effect of combined transcranial direct current stimulation and Matrix ‎Model on the reduction of methamphetamine craving and improvement of cognitive ‎functioning: a randomized sham-contro	5
Longitudinal factors associated with increased alcohol consumption in adults during the COVID-19 pandemic	5
Interpersonal communication and perceived norms as social influence mechanisms of e-cigarette use among adults: a systematic review	5
Applied statistical methods for identifying features of heart rate that are associated with nicotine vaping	5
Hospital adoption of harm reduction and risk education strategies to address substance use disorders	5
Effects of current smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study	5
Quantitative and qualitative outcomes associated with inpatient addiction consultation: a scoping review	5
Cannabis use among pregnant women under different legalization frameworks in the United States	5
Changes in the proportion of fatal overdoses by substance type in the US, 1999–2021	5
A targeted approach to using e-cigarettes for harm reduction in adults	4
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C	4
Seeing the forest for the trees: a commentary on ‘real-world’ e-cigarette use and readiness to stop smoking among adults who smoke	4
The prevalence of alcohol use and risky driving practises among individuals who consume sedatives nonmedically: findings from the NESARC-III	4
Evaluation of an online SBIRT training program	4
Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis	4
Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation	4
The association of alcohol consumption with the risk of sarcopenia: a dose-response meta-analysis	4
TLR3 activation with poly I:C exacerbates escalated alcohol consumption in dependent male C57BL/6J mice	4
Historical and contextual variation in daily opioid consumption rates: implications for supply control, service delivery, and research	4
Non-prescription pharmacy syringes sales to people who inject drugs (PWID) in Khartoum, Sudan: policy, practice, and perceptions	4
Comparing substance-involved suicide and unintentional deaths from 2011 to 2021 in Missouri, United States	4
Implementing an EMA burst design in community-engaged research: participant and researcher perspectives and recommendations	4
Psychometric evaluation of two indices assessing stigma toward opioid misuse and treatment among health care providers	4
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature	4
Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis	4
Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system	4
Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic	4
Psychometric properties and invariance testing of the Cannabis Refusal Self-Efficacy Scale in a Chilean sample	4
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder	4
Fentanyl and other opioid involvement in methamphetamine-related deaths	4
The hidden-zero effect in male individuals with opioid use disorder	4
Healthcare professionals’ and budtenders’ perceptions of perinatal cannabis use	4
Harm reduction as treatment for Black and Hispanic individuals: response to Scheidell et al	4
Missouri’s Overdose Field Report: descriptive analysis, survival trends, and naloxone dosing patterns from a community-based survey tool, 2018–2022	3
Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports	3
Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder	3
Simulated opioid choice linked to opioid use disorder severity among veterans with chronic pain: initial validation of a novel paradigm	3
Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members	3
Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders	3
Experiencing violence and other predictors of within-person same-day use of multiple substances in youth: a longitudinal study in emergency settings	3
Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection	3
Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder	3
Adolescent stress avoidance influences cue-induced heroin seeking and chaperonin gene expression in the dorsal striatum of adult female rats	3
Trends in the availability of comprehensive services within outpatient substance use treatment facilities from 2018 to 2022	3
Cigarette and e-cigarette use as a function of psychological distress following COVID-19 related university campus closures	3
The role of sleep in the link between cannabis use and memory function: evidence from a cross-sectional study	3
Flumazenil partially reverses gamma-hydroxybutyrate (GHB)-induced coma: a case report	3
Characterization of quality of life among individuals with current treated, untreated, and past alcohol use disorder	3
Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment	3
Increased risk of non-fatal overdose associated with broad adverse childhood experiences among people who use drugs in New York City: a latent class analysis	3
Family history, childhood maltreatment, and adolescent binge drinking exert synergistic effects on delay discounting and future alcohol use	3
Targeting the Nlrp3 inflammasome as potential treatment for ethanol-induced non-communicable diseases	3
Possible substance use disorders among first responders during the COVID-19 era: a quasi-experimental study of personal and residential vulnerability	3
Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis	3
Safety and tolerability of progesterone treatment for women with cocaine use disorder: a pilot treatment trial	3
Successful treatment of dextromethorphan use disorder with combined naltrexone and gabapentin: a case report	3
Alcohol self-administration and nicotine withdrawal alter biomarkers of stress and inflammation and prefrontal cortex changes in Gβ subunits	3
The challenge of unrecorded alcohol consumption in Argentina: estimation and key predictors	2
Effectiveness of psychosocial interventions for alcohol use disorder: a systematic review and meta-analysis update	2
New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature	2
Opioid use disorder Cascade of Care: defining a taxonomy for measurement	2
Psychometric properties of the Fletcher Recovery Housing Alliance Measure (FRHAM-12)	2
Alcohol use severity among Hispanic college students: examining social media discrimination, drinking motives, and resilience in a stress and coping framework	2
Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone	2
Adolescent’s explicit and implicit cigarette cognitions predict experimentation with both cigarettes and e-cigarettes	2
Safety and efficacy of ketamine for the treatment of patients with alcohol use disorder: a systematic review	2
Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT1A receptors	2
Exploring the impact of inflammatory cytokines on alcoholic liver disease: a Mendelian randomization study with bioinformatics insights into potential biological mechanisms	2
Reasons for use and experiences of using phenibut, a mixed methods analysis of online reports	2
A national longitudinal study of sexual orientation discordance, sexual identity fluidity, and alcohol and other drug use disorder symptoms	2
Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.”	2
Psychometric properties and Longitudinal Measurement Invariance of the Spanish version of the Alcohol Expectancies Questionnaire Short Form among young adult binge drinkers	2
Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R/AKT/GSK3β/CREB signaling pathway	2
Alcohol use among adult recent Latino/a immigrants: the role of stress, forced migration, and adherence to traditional gender roles	2
Comparison of the imaging and clinical characteristics between Initial and Recurrent Alcoholic Acute Pancreatitis: a retrospective cross-sectional study	2
Understanding readmission to substance use disorder treatment in Chile: a mixed-method study	2

Sensitivity, specificity and predictive values of ICD-10 substance use codes in a cohort of substance use-related endocarditis patients	2
Changes in alcohol consumption and binge drinking during the COVID-19 pandemic among American Indians residing in California and Oklahoma	2
Laboratory method to induce state boredom increases impulsive choice in people who use cocaine and controls	2
Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample	2
Focusing on protective factors, resilience and thriving to reduce health disparities and treatment inequities	2
Practical foundations of machine learning for addiction research. Part I. Methods and techniques	2
Extended-release buprenorphine outcomes among treatment resistant veterans	2
Supporting medication-assisted recovery in recovery residences: staff support, managing built environment threats, and building a supportive network	2
Risk, resilience, and thriving among racial/ethnic minorities and underserved populations at-risk for substance use disorders	2
Kratom use as more than a “self-treatment”	2
A systematic meta-epidemiologic review on nonabstinence-inclusive interventions for substance use: inclusion of race/ethnicity and sex assigned at birth/gender	2
Substance use and help seeking as coping behaviors among parents and unpaid caregivers of adults in the United States during the COVID-19 pandemic	2